Immunomodulatory action of levamisole - I. Structural analysis and immunomodulating activity of levamisole degradation products

Kimberly A Hanson, Donald L. Nagel, Margaret L. Heidrick

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In our laboratory we observed that solutions of levamisole (LMS) stored at 4°C consistently enhanced the lymphocyte proliferation response to concanavalin A (Con A) more than freshly prepared solutions did. To determine if the increased immunopotentiation observed with the stored solutions of LMS was due to products formed from LMS, we assessed the stability of LMS when stored at 4 or 37°C at pH 6, 7, 7.5 and 8. Analysis of the various solutions by high pressure liquid chromatography demonstrated that LMS decomposes during storage in neutral and alkaline conditions to form three products. The formation of the products was accelerated by increasing the temperature from 4 to 37°C. The three degradation products were purified by preparative high pressure liquid chromatography and their structures determined by mass spectrometry, infrared spectrometry and homo- and heteronuclear two dimensional nuclear magnetic resonance spectroscopy. The degradation products, denoted as No. 1, No. 2 and No. 3, based on their high pressure liquid chromatography retention times, were identified as: No. 1, 3-(2-mercaptoethyl)-5-phenylimidazolidine-2-one; No. 2, 6-phenyl-2,3-dihydroimidazo (2,1-b) thiazole and No. 3, bis [3-(2-oxo-5-phenylimidazolidin-1-yl) ethyl] disulfide. Product 2 significantly enhanced murine lymphocyte proliferation responses to concanavalin A (Con A) at concentrations between 0.5 and 10.0 μg/ml (whereas the optimum concentration of LMS is 10 - 100 fold higher (50 - 100 μg/ml)). Products 1, 2 and 3 significantly inhibited the lymphocyte proliferative response at concentrations >2.2, 10.0 and 10.0 μg/ml, respectively. These studies indicate that under relatively mild conditions, including physiological conditions, LMS may decompose to products which inhibit or enhance lymphocyte responses to Con A.

Original languageEnglish (US)
Pages (from-to)655-668
Number of pages14
JournalInternational Journal of Immunopharmacology
Volume13
Issue number6
DOIs
StatePublished - Jan 1 1991

Fingerprint

Levamisole
Lymphocytes
High Pressure Liquid Chromatography
Concanavalin A
Thiazoles
Disulfides
Mass Spectrometry
Spectrum Analysis
Magnetic Resonance Spectroscopy
Temperature

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this

Immunomodulatory action of levamisole - I. Structural analysis and immunomodulating activity of levamisole degradation products. / Hanson, Kimberly A; Nagel, Donald L.; Heidrick, Margaret L.

In: International Journal of Immunopharmacology, Vol. 13, No. 6, 01.01.1991, p. 655-668.

Research output: Contribution to journalArticle

@article{8d3cdf5678214fdfaeec57e00e5177d9,
title = "Immunomodulatory action of levamisole - I. Structural analysis and immunomodulating activity of levamisole degradation products",
abstract = "In our laboratory we observed that solutions of levamisole (LMS) stored at 4°C consistently enhanced the lymphocyte proliferation response to concanavalin A (Con A) more than freshly prepared solutions did. To determine if the increased immunopotentiation observed with the stored solutions of LMS was due to products formed from LMS, we assessed the stability of LMS when stored at 4 or 37°C at pH 6, 7, 7.5 and 8. Analysis of the various solutions by high pressure liquid chromatography demonstrated that LMS decomposes during storage in neutral and alkaline conditions to form three products. The formation of the products was accelerated by increasing the temperature from 4 to 37°C. The three degradation products were purified by preparative high pressure liquid chromatography and their structures determined by mass spectrometry, infrared spectrometry and homo- and heteronuclear two dimensional nuclear magnetic resonance spectroscopy. The degradation products, denoted as No. 1, No. 2 and No. 3, based on their high pressure liquid chromatography retention times, were identified as: No. 1, 3-(2-mercaptoethyl)-5-phenylimidazolidine-2-one; No. 2, 6-phenyl-2,3-dihydroimidazo (2,1-b) thiazole and No. 3, bis [3-(2-oxo-5-phenylimidazolidin-1-yl) ethyl] disulfide. Product 2 significantly enhanced murine lymphocyte proliferation responses to concanavalin A (Con A) at concentrations between 0.5 and 10.0 μg/ml (whereas the optimum concentration of LMS is 10 - 100 fold higher (50 - 100 μg/ml)). Products 1, 2 and 3 significantly inhibited the lymphocyte proliferative response at concentrations >2.2, 10.0 and 10.0 μg/ml, respectively. These studies indicate that under relatively mild conditions, including physiological conditions, LMS may decompose to products which inhibit or enhance lymphocyte responses to Con A.",
author = "Hanson, {Kimberly A} and Nagel, {Donald L.} and Heidrick, {Margaret L.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/0192-0561(91)90178-A",
language = "English (US)",
volume = "13",
pages = "655--668",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Immunomodulatory action of levamisole - I. Structural analysis and immunomodulating activity of levamisole degradation products

AU - Hanson, Kimberly A

AU - Nagel, Donald L.

AU - Heidrick, Margaret L.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - In our laboratory we observed that solutions of levamisole (LMS) stored at 4°C consistently enhanced the lymphocyte proliferation response to concanavalin A (Con A) more than freshly prepared solutions did. To determine if the increased immunopotentiation observed with the stored solutions of LMS was due to products formed from LMS, we assessed the stability of LMS when stored at 4 or 37°C at pH 6, 7, 7.5 and 8. Analysis of the various solutions by high pressure liquid chromatography demonstrated that LMS decomposes during storage in neutral and alkaline conditions to form three products. The formation of the products was accelerated by increasing the temperature from 4 to 37°C. The three degradation products were purified by preparative high pressure liquid chromatography and their structures determined by mass spectrometry, infrared spectrometry and homo- and heteronuclear two dimensional nuclear magnetic resonance spectroscopy. The degradation products, denoted as No. 1, No. 2 and No. 3, based on their high pressure liquid chromatography retention times, were identified as: No. 1, 3-(2-mercaptoethyl)-5-phenylimidazolidine-2-one; No. 2, 6-phenyl-2,3-dihydroimidazo (2,1-b) thiazole and No. 3, bis [3-(2-oxo-5-phenylimidazolidin-1-yl) ethyl] disulfide. Product 2 significantly enhanced murine lymphocyte proliferation responses to concanavalin A (Con A) at concentrations between 0.5 and 10.0 μg/ml (whereas the optimum concentration of LMS is 10 - 100 fold higher (50 - 100 μg/ml)). Products 1, 2 and 3 significantly inhibited the lymphocyte proliferative response at concentrations >2.2, 10.0 and 10.0 μg/ml, respectively. These studies indicate that under relatively mild conditions, including physiological conditions, LMS may decompose to products which inhibit or enhance lymphocyte responses to Con A.

AB - In our laboratory we observed that solutions of levamisole (LMS) stored at 4°C consistently enhanced the lymphocyte proliferation response to concanavalin A (Con A) more than freshly prepared solutions did. To determine if the increased immunopotentiation observed with the stored solutions of LMS was due to products formed from LMS, we assessed the stability of LMS when stored at 4 or 37°C at pH 6, 7, 7.5 and 8. Analysis of the various solutions by high pressure liquid chromatography demonstrated that LMS decomposes during storage in neutral and alkaline conditions to form three products. The formation of the products was accelerated by increasing the temperature from 4 to 37°C. The three degradation products were purified by preparative high pressure liquid chromatography and their structures determined by mass spectrometry, infrared spectrometry and homo- and heteronuclear two dimensional nuclear magnetic resonance spectroscopy. The degradation products, denoted as No. 1, No. 2 and No. 3, based on their high pressure liquid chromatography retention times, were identified as: No. 1, 3-(2-mercaptoethyl)-5-phenylimidazolidine-2-one; No. 2, 6-phenyl-2,3-dihydroimidazo (2,1-b) thiazole and No. 3, bis [3-(2-oxo-5-phenylimidazolidin-1-yl) ethyl] disulfide. Product 2 significantly enhanced murine lymphocyte proliferation responses to concanavalin A (Con A) at concentrations between 0.5 and 10.0 μg/ml (whereas the optimum concentration of LMS is 10 - 100 fold higher (50 - 100 μg/ml)). Products 1, 2 and 3 significantly inhibited the lymphocyte proliferative response at concentrations >2.2, 10.0 and 10.0 μg/ml, respectively. These studies indicate that under relatively mild conditions, including physiological conditions, LMS may decompose to products which inhibit or enhance lymphocyte responses to Con A.

UR - http://www.scopus.com/inward/record.url?scp=0025952308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025952308&partnerID=8YFLogxK

U2 - 10.1016/0192-0561(91)90178-A

DO - 10.1016/0192-0561(91)90178-A

M3 - Article

VL - 13

SP - 655

EP - 668

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 6

ER -